Correction: J Exp Clin Cancer Res 41, 112 (2022)https://doi.org/10.1186/s13046-022-02320-6Following publication of the original article [1], author would like to correct the Funding section statement.Incorrect Funding:This research was funded by Fondazione AIRC under 5 per Mille 2018 – ID 21052 program - PI: Comoglio PM, GL: Vigna E; by FPRC 5xmille 2014 Ministero Salute to PMC, and by Ministero Salute, Ricerca Corrente 2018–2020. The studies performed by Accelera Srl. were sponsored by Metis Precision Medicine B-Corp.Correct Funding:This research was funded by Fondazione AIRC under 5 per Mille 2018 - ID 21052 program - PI: Comoglio PM, GL: Vigna E; by Italian Association for Cancer Research (AIRC), IG 20210 to S. Giordano, and IG 21770 to S. Corso; by FPRC 5xmille 2014 Ministero Salute to PMC, and by Ministero Salute, Ricerca Corrente 2018-2020. The studies performed by Accelera Srl. were sponsored by Metis Precision Medicine B-Corp.The correction does not have any effect on the final conclusions of the paper. The original article has been corrected.
Authors: Ilaria Martinelli; Chiara Modica; Cristina Chiriaco; Cristina Basilico; James M Hughes; Simona Corso; Silvia Giordano; Paolo M Comoglio; Elisa Vigna Journal: J Exp Clin Cancer Res Date: 2022-03-29